Insider Transactions Reported by 16 Insiders of Karuna Therapeutics, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Karuna Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Troy A. Ignelzi Chief Financial Officer $18,263,346 22 Aug 2023
Charmaine Lykins Chief Commercial Officer $6,922,500 29 Nov 2021
Heather Preston Director $2,861,556 24 Jun 2021
David E. Wheadon Director $0 18 Mar 2024
LAURIE J. OLSON Director $0 18 Mar 2024
William P. Kane Jr Chief Commercial Officer $0 18 Mar 2024
Andrew Craig Miller President of R&D $0 18 Mar 2024
JAMES HEALY Director $0 18 Mar 2024
Atul Pande Director $0 18 Mar 2024
William Meury President and CEO, Director $0 18 Mar 2024
COUGHLIN CHRISTOPHER J Director $0 18 Mar 2024
Stephen K. Brannan Chief Medical Officer $0 18 Mar 2024
STEVEN M. PAUL Director $0 18 Mar 2024
Jason Brown Chief Financial Officer $0 18 Mar 2024
Denice Torres Director $0 18 Mar 2024
JEFFREY M. JONAS Director $0 15 Mar 2024

Recent Insider Transactions by Companies or Individuals for Karuna Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.